We are live on
!
Find out more
TCM
Tao Capital Management Portfolio holdings
AUM
$119M
1-Year Est. Return
87.46%
This Fund
S&P 500
This Quarter
Est. Return
+51.85%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
–
AUM
$310M
AUM Growth
+$57.2M
(+23%)
Cap. Flow
-$65.2M
Cap. Flow
% of AUM
-21.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
3
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$5.58M |
| 2 |
TPIC
TPI Composites
TPIC
|
+$151K |
| 3 |
Palantir
PLTR
|
+$107K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$65.5M |
| 2 |
Twist Bioscience
TWST
|
+$5.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.4% |
| 2 | Healthcare | 32.14% |
| 3 | Consumer Discretionary | 25.41% |
| 4 | Industrials | 0.05% |
Similar funds
SF
MWM
VA
HPM
SKK
WKSWA
CA
LC
Tao Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Tao Capital Management held 7 positions worth $310M, up 23% from $253M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tao Capital Management withdrew a net $65.2M in Q3 2020, reducing 2 holdings. Its largest reduction was Tesla, cutting an estimated $65.5M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 44% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Tao Capital Management opened a new position in Madrigal Pharmaceuticals worth $6.1M.
- Tao Capital Management's largest Q3 2020 buy was Madrigal Pharmaceuticals: 51,396 shares worth $6.1M.
- Tao Capital Management's biggest Q3 2020 reduction was Tesla, cutting an estimated $65.5M.
- Tao Capital Management's ten largest holdings make up 100% of its $310M portfolio in Q3 2020.
- Tao Capital Management opened 3 new positions and closed 0 in Q3 2020.
- Tao Capital Management's portfolio value rose 23% quarter-over-quarter to $310M.
Based on Tao Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.